# RAAPID

> RAAPID sells clinical AI software and coding services for evidence-linked risk adjustment. Its platform supports retrospective chart review, prospective physician workflows, RADV audit preparation and integration through clinical APIs for health plans and providers.

- **Founded:** 2022
- **Headquarters:** Louisville, United States
- **Founders:** Chetan Parikh (Founder & CEO), Vatsal Ghiya (Co-Founder & CMO)
- **Products:** Retrospective Risk Adjustment, Prospective Risk Adjustment, RADV Audit Solution, Clinical AI APIs / AI as a Service
- **Notable:** Modern Healthcare 2025 Best in Business honoree in Healthcare IT, announced January 2026., RAAPID announced HITRUST r2 certification for its platform on Microsoft Azure East in June 2026., May 2026 KLAS Emerging Company Spotlight; RAAPID reports all five interviewed respondents would buy again.

## Products & services

- **Retrospective Risk Adjustment** — Chart prioritization, HCC identification, evidence validation and review of missing or unsupported codes.
- **Prospective Risk Adjustment** — Pre-visit evidence review, physician-facing suspected conditions and post-visit documentation checks.
- **RADV Audit Solution** — Audit workflow software and AI-assisted review with certified auditor support.
- **Clinical AI APIs / AI as a Service** — APIs for coding, clinical entity extraction, medical terminologies and protected health information de-identification.

## Achievements

- Modern Healthcare 2025 Best in Business honoree in Healthcare IT, announced January 2026.
- RAAPID announced HITRUST r2 certification for its platform on Microsoft Azure East in June 2026.
- May 2026 KLAS Emerging Company Spotlight; RAAPID reports all five interviewed respondents would buy again.
- Company reported 300% revenue growth in 2024; absolute revenue was not disclosed.

## Latest updates

- **2026-06** — Announced HITRUST r2 certification for the Azure East-hosted platform.
- **2026-05** — Featured in KLAS Emerging Company Spotlight; company-published ratings are marked emerging data, n=5.
- **2026-04** — Announced Healthworx strategic investment.
- **2026-03** — Announced Series A extension from UPMC Enterprises.

## Links

- Website: https://www.raapidinc.com/
- LinkedIn: https://www.linkedin.com/company/raapid/
- Twitter/X: https://twitter.com/raapidinc
- YouTube: https://www.youtube.com/@raapidai/
- Instagram: https://www.instagram.com/raapidinc/
- Facebook: https://www.facebook.com/raapidai/

---

Profile page: https://yespress.io/raapid
Published by YesPress — https://yespress.io
Last updated: 2026-10-23